Search research articles
Contact Us
Filters
Showing results (781-790 of 968) with videos related to
Page
of 97
Sort By:
Nuclear Medicine Communications
|
September 1, 1996
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodies
T M Behr, M E Juweid, R M Sharkey, et al.
Cancer Research
|
June 19, 2008
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma
David V Gold, David M Goldenberg, Habibe Karacay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1994
The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels
L B Shih, S R Thorpe, G L Griffiths, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2015
Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan)
Robert M Sharkey, William J McBride, Thomas M Cardillo, et al.
The Journal of the American Association of Gynecologic Laparoscopists
|
May 9, 2001
Hysteroscopy may be the method of choice for management of residual trophoblastic tissue
S B Cohen, A Kalter-Ferber, B S Weisz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 20, 2011
Optimized labeling of NOTA-conjugated octreotide with F-18
Peter Laverman, Christopher A D'Souza, Annemarie Eek, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 8, 2012
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)
Françoise Kraeber-Bodéré, Pierre-Yves Salaun, Catherine Ansquer, et al.
International Journal of Cancer
|
July 29, 2011
Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo
David M Goldenberg, David Zagzag, Kerstin M Heselmeyer-Haddad, et al.
Leukemia & Lymphoma
|
September 22, 2015
Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia
Matt E Kalaycio, O George Negrea, Steven L Allen, et al.
Clinical Colorectal Cancer
|
November 28, 2002
Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer
George Hajjar, Robert M Sharkey, Jack Burton, et al.
Page
of 97
Search research articles
Search
Showing results (781-790 of 968) with videos related to
Sort By:
Page
of 97
Nuclear Medicine Communications
|
September 1, 1996
Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodies
T M Behr, M E Juweid, R M Sharkey, et al.
Cancer Research
|
June 19, 2008
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma
David V Gold, David M Goldenberg, Habibe Karacay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 1, 1994
The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels
L B Shih, S R Thorpe, G L Griffiths, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2015
Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan)
Robert M Sharkey, William J McBride, Thomas M Cardillo, et al.
The Journal of the American Association of Gynecologic Laparoscopists
|
May 9, 2001
Hysteroscopy may be the method of choice for management of residual trophoblastic tissue
S B Cohen, A Kalter-Ferber, B S Weisz, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 20, 2011
Optimized labeling of NOTA-conjugated octreotide with F-18
Peter Laverman, Christopher A D'Souza, Annemarie Eek, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 8, 2012
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)
Françoise Kraeber-Bodéré, Pierre-Yves Salaun, Catherine Ansquer, et al.
International Journal of Cancer
|
July 29, 2011
Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo
David M Goldenberg, David Zagzag, Kerstin M Heselmeyer-Haddad, et al.
Leukemia & Lymphoma
|
September 22, 2015
Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia
Matt E Kalaycio, O George Negrea, Steven L Allen, et al.
Clinical Colorectal Cancer
|
November 28, 2002
Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer
George Hajjar, Robert M Sharkey, Jack Burton, et al.
Page
of 97